Stock listing

NASDAQ:BOLT Bolt Biotherapeutics, Inc. Stock

Home listing (NASDAQ) of Bolt Biotherapeutics, Inc.

Follow Bolt Biotherapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BOLT

$6.57 USD +0.33 (+5.3%)

Close on Nov 3, 2026

Past year +17.7% · daily closes, Nov 3, 2025 – Nov 3, 2026, adjusted for splits
Day range
$6.10 – $6.74 USDNov 3, 2026
Volume
51,390 sharesNov 3, 2026
Market cap
$15.49M USDAt the close on Nov 3, 2026 · price × 2.36M shares outstanding
52-week range
$3.10 – $7.78 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
Traded on an average day
$1.43M USDMedian day 20,561 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Bolt Biotherapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BOLT · Home$6.57 USD+0.33 (+5.3%)51,390$6.32$6.74$6.10$6.24Close on Nov 3, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:BOLT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.57+0.33+5.3%$6.32$6.74$6.1051,390
$6.24-0.35-5.3%$6.58$6.58$6.1850,400
$6.59+0.23+3.6%$6.28$6.59$6.09249,911
$6.36-0.22-3.3%$6.47$6.61$6.3076,266
$6.58+0.21+3.3%$6.34$6.60$6.2882,387
$6.37-0.22-3.3%$6.58$6.64$6.22176,351
$6.59+0.32+5.1%$6.66$6.865$6.20420,175
$6.27+2.08+49.6%$6.98$7.78$5.9912,882,703
$4.19+0.05+1.2%$4.06$4.21$4.02614,054
$4.14-0.17-3.9%$4.33$4.48$4.0534,466
$4.31+0.27+6.7%$4.05$4.33$4.0529,274
$4.04+0.04+1.0%$3.947$4.20$3.94721,942
$4.00-0.24-5.7%$4.46$4.48$3.95510,118
$4.24+0.26+6.5%$4.14$4.44$3.859,255
$3.98-0.305-7.1%$4.28$4.375$3.7631,070
$4.285+0.045+1.1%$4.26$4.385$4.2512,826
$4.24+0.13+3.2%$4.13$4.678$4.1328,728
$4.11+0.46+12.6%$3.77$4.40$3.7787,217
$3.65+0.05+1.4%$3.545$3.65$3.44710,484
$3.60+0.09+2.6%$3.65$3.79$3.38154,000
$3.51+0.011+0.3%$3.453$3.639$3.45323,259
$3.499+0.049+1.4%$3.708$3.708$3.389,776
$3.45-0.06-1.7%$3.495$3.495$3.45885
$3.51-0.17-4.6%$3.61$3.615$3.4821,671
$3.68+0.08+2.2%$3.65$3.78$3.5979,309
$3.60+0.14+4.0%$3.46$3.65$3.469,548
$3.46-0.12-3.3%$3.64$3.78$3.4619,973
$3.58-0.01-0.3%$3.60$3.68$3.584,101
$3.59-0.06-1.6%$3.57$3.71$3.46515,280
$3.65-0.06-1.6%$3.90$3.90$3.575,105
$3.71+0.12+3.3%$3.655$3.80$3.4517,854
$3.59+0.03+0.8%$3.465$3.64$3.3822,454
$3.56+0.215+6.4%$3.32$3.62$3.10249,406
$3.345-0.285-7.9%$3.67$3.67$3.2090,467
$3.63-0.40-9.9%$3.92$4.233$3.6129,004
$4.03+0.05+1.3%$3.98$4.36$3.8645,827
$3.98+0.03+0.8%$3.835$4.09$3.7019,634
$3.95+0.22+5.9%$3.72$3.955$3.5777,076
$3.73+0.052+1.4%$3.69$3.83$3.2596,974
$3.678-0.182-4.7%$3.87$3.92$3.6784,258
$3.86-0.04-1.0%$3.90$3.935$3.537,348
$3.90+0.005+0.1%$3.90$4.00$3.8458,506
$3.895+0.055+1.4%$3.81$3.98$3.805,553
$3.84-0.23-5.7%$4.01$4.10$3.8434,539
$4.07+0.09+2.3%$4.00$4.15$3.958,087
$3.98+0.165+4.3%$3.92$4.04$3.804,958
$3.815-0.185-4.6%$3.97$4.27$3.7424,986
$4.00+0.08+2.0%$3.82$4.00$3.827,708
$3.92+0.07+1.8%$3.785$3.95$3.7853,750
$3.85+0.11+2.9%$3.82$3.852$3.7432,389
$3.74+0.075+2.0%$3.65$3.93$3.6511,125
$3.665+0.465+14.5%$3.24$3.78$3.20265,317
$3.20-0.06-1.8%$3.39$3.57$3.1522,008
$3.26+0.083+2.6%$3.29$3.308$3.1821,148
$3.177-0.023-0.7%$3.22$3.28$3.167,335
$3.20-0.15-4.5%$3.23$3.736$3.2024,576
$3.35+0.14+4.4%$3.30$3.35$3.2015,961
$3.21-0.24-7.0%$3.40$3.45$3.2128,389
$3.45-0.53-13.3%$3.915$3.94$3.13200,171
$3.98-0.01-0.3%$4.04$4.082$3.9410,282
$3.99-0.06-1.5%$4.05$4.05$3.9312,993
$4.05+0.18+4.7%$4.15$4.15$3.8715,175
$3.87-0.08-2.0%$3.82$3.95$3.7832,781
$3.950.000.0%$4.05$4.05$3.958,721
$3.95-0.03-0.8%$4.10$4.10$3.912,310
$3.98-0.01-0.3%$3.90$4.01$3.8119,964
Ticker
NASDAQ:BOLT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Bolt Biotherapeutics (NASDAQ:BOLT) Q1 2024 Earnings Call

    Tue, May 14, 2024 · 4:30 PM ET

    Watch Transcript

Latest news

All Bolt Biotherapeutics, Inc. news

Financings

  • Private placement of series D non-voting convertible preferred stock and accompanying warrants

    Oct 23, 2026

    Announced: US$120M · US$8,574 a share · Warrants at US$8,574 · Jefferies LLC +4

    Dealers: Jefferies LLC, TD Cowen, Stifel, LifeSci Capital, Tungsten Advisors

    Buyers: Deep Track Capital; ADAR1 Capital; Andreessen Horowitz (a16z); LYFE Capital; Coastlands Capital; Eventide Asset Management; Casdin Capital; Curie.Bio; SilverArc Capital; Soleus Capital; Deviation Capital

    Use of proceeds: Fund operations into 2028 and through multiple anticipated clinical and preclinical milestones

    Announced Oct 23, 2026

Read by 6ix AI from the company's releases

Decks

Bolt Biotherapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
6 in the last 12 months · 72 in all · newest Nov 3, 2026 · oldest 2021
Calls
1 call with a replay · 1 with a transcript · latest May 14, 2024
Decks
6 decks · latest Oct 23, 2026

Where Bolt Biotherapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BOLT · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BOLTBOATSUnited StatesUSD
Frankfurt:6LP0FrankfurtGermanyEUR
gettex:6LP0gettexGermanyEUR
Lang & Schwarz:A419U9Lang & SchwarzGermanyEUR
LS Exchange:A419U9LS ExchangeGermanyEUR
Munich:6LP0MunichGermanyEUR

Log in to ask 6ix AI your own questions about Bolt Biotherapeutics, Inc.